Get in Touch: 1-888-253-3960 enquiry@vynzresearch.com
Non-Invasive Prenatal Testing Market Š 2018 VynZ Research All rights reserved
About VynZ Research… VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.
VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved.
A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts.
Serving wide range of customers most of them from Fortune 2000 companies
With a dedicated 24x7 customer helpline our customers can reach for specifying their needs
Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.
© 2018 VynZ Research All rights reserved
Global Non-Invasive Prenatal Testing Market
Non-invasive prenatal testing (NIPT) is a sensitive diagnosis method for identifying specific chromosomal abnormalities in the developing fetus. Chromosomal disorders such as Turner syndrome, Edwards syndrome, Patau syndrome, and down syndrome are some of the diseases which are screened using NIPT. The global noninvasive prenatal testing market is growing at a significant rate, due to mounting occurrence of chromosomal abnormalities, mounting maternal age and introduction of advanced products. Different products contributed to the Š 2018 VynZ Research All rights reserved
non-invasive prenatal testing market size.
Global Non-Invasive Prenatal Testing Market
The refining reimbursement scenario for NIPT, mounting occurrence of chromosomal abnormalities, Mounting average maternal age, and introduction of advanced products are the primary growth drivers for the non-invasive prenatal testing market. For instance, according to the World Health Organization (WHO), each year approximately 3,000 to 5,000 children are born with a chromosome disorder. Budding inclination for non-invasive techniques, mounting healthcare expenditure and programs focusing on boosting the alertness of NIPT are also facilitating the growth for the non-invasive prenatal testing market.
Š 2018 VynZ Research All rights reserved
Global Non-Invasive Prenatal Testing Market Asia-Pacific is observed to witness the fastest growth in the market, due to mounting healthcare expenditure. In addition, boosting alertness programs and conferences are also creating a positive impact on the Non-invasive prenatal testing market growth in the region. Key players in the non-invasive prenatal testing market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In December 2017, PerkinElmer, Inc. acquired EUROIMMUN Medical Laboratory Diagnostics AG, to strengthen its position in China and other emerging countries. GE Healthcare, Perkinelmer, Inc., Koninklijke N.V., Qiagen, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., and Beijing Genomics Institute are the key players offering non-invasive prenatal testing. Š 2018 VynZ Research All rights reserved
For Sample Report :https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sampl e
www.vynzresearch.com
Š 2018 VynZ Research All rights reserved